Interleukin-10 receptor-2 peptides, antibodies, compositions, and methods of use thereof
US-2019077859-A1 · Mar 14, 2019 · US
Compositions and methods of use of interleukin-10 peptides and anti-interleukin-10 antibodies
US11319367B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11319367-B2 |
| Application number | US-201916596839-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 9, 2019 |
| Priority date | Mar 27, 2015 |
| Publication date | May 3, 2022 |
| Grant date | May 3, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein are methods of reducing a symptom of respiratory disease in a pre-weaned milk-fed mammal by orally administering an isolated antibody that specifically binds the interleukin-10 peptide or an anti-interleukin-10 antibody. Also included are methods of reducing mixing stress in human and non-human mammals by administering an isolated antibody that specifically binds the interleukin-10 peptide or an anti-interleukin-10 antibody. Further included are milk and food compositions including the interleukin-10 peptide or anti-interleukin-10 antibody.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of reducing a symptom of a bovine respiratory disease complex in a pre-weaned bovine, comprising orally administering to the pre-weaned bovine an effective amount of an egg yolk preparation comprising an isolated antibody that specifically binds an interleukin-10 peptide of SEQ ID NO:2, wherein said antibody is a polyclonal avian egg yolk IgY antibody preparation produced by inoculating laying hens with the interleukin-10 peptide of SEQ ID NO:2; wherein administration is initiated between birth and weaning, and wherein administration is performed at least once daily for a period of 7 days to 7 weeks; and wherein the symptom of bovine respiratory disease complex is increased fecal Cryptosporidium parvum , reduced weight gain, decreased fecal pH, or a combination thereof. 2. The method of claim 1 , wherein administration of the egg yolk preparation is stopped after the 7 day to 7 week period and is not restarted for 1 to 14 days. 3. The method of claim 1 , wherein the bovine is 56 days of age or younger. 4. The method of claim 1 , wherein the egg yolk preparation comprising the isolated antibody that specifically binds the interleukin-10 peptide is administered in a milk composition.
Assignees
Inventors
Classifications
comprising antibodies · CPC title
Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues · CPC title
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title
Antiparasitic agents · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11319367B2 cover?
- Disclosed herein are methods of reducing a symptom of respiratory disease in a pre-weaned milk-fed mammal by orally administering an isolated antibody that specifically binds the interleukin-10 peptide or an anti-interleukin-10 antibody. Also included are methods of reducing mixing stress in human and non-human mammals by administering an isolated antibody that specifically binds the interleuki…
- Who is the assignee on this patent?
- Wisconsin Alumni Res Found
- What technology area does this patent fall under?
- Primary CPC classification C07K16/244. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).